This is the situation that Jamie Goldfarb faced, who never thought that she would be diagnosed with melanoma, a type of skin cancer. She was diagnosed with stage 2 melanoma that was treated successfully. However, the very next year stage 3 melanoma was also diagnosed. Treatment was successful this time as well. All scans like PET scans showed that she was fully cured after surgery and there were no remanents of this disease.

Jamie was happy and moving on with her life. She also had a child after her recovery and was going to return to her career soon. Life seemed right on track but all of a sudden something happened that was totally unexpected – Jamie was diagnosed with stage 4 melanoma this time!
Stage 4 is an advanced stage of cancer. On this stage, cancer spreads to the other parts of the body from its place of origin. So was the case with Jamie – cancer had spread to her liver and pancreas. Jamie desperately wanted this news to be wrong but unfortunately, it was true.
Stage 4 cancer survival rate is very low. Five-year survival rate with stage 4 melanoma is around 15%-20%. Jamie had a small child and a whole life ahead of her. She and her husband knew that a prognosis of stage 4 melanoma is not good with standard treatment protocol. That is when they decided to give a go to a clinical trial. Jamie was ready to take her chance because it seemed the best option at that point. She enrolled for TILs or tumor-infiltrating lymphocytes trial after consulting with experts. This treatment was supposed to kill cancer cells considering them foreign invaders.